Ontario Institute for Cancer Research (OICR) is a collaborative, not-for-profit research institute funded by the Government of Ontario. We conduct and enable high-impact translational cancer research to accelerate the development of discoveries for patients around the world while maximizing the economic benefit of this research for the people of Ontario.


The Ontario Hereditary Cancer Research Network (OHCRN) is hosted and funded by OICR and is the first registry of its kind in Canada.  Approximately 10% of all cancer case are caused by inherited factors and individuals with hereditary cancer syndromes have a high likelihood of developing the disease over their lifetimes. OHCRN will centralize clinical and genetic information for individuals at risk of hereditary cancer syndromes and help connect participants to researchers across the province.


OHCRN will inclusively enable access to clinical trials, precision therapy and gene discovery. OHCRN is engaging the community through patient partnerships and provincial collaborations to ensure that knowledge gained through the network is used directly to improve clinical care.


With enhanced identification and monitoring of carriers of hereditary cancer syndromes, we will better understand the biology, prevention, early detection and treatment of hereditary cancers – and cancer in general.


If anyone would like more information on OHCRN or OICR, please feel free to contact OHCRN Program Manager Lauren Hughes (lauren.hughes@oicr.on.ca) or Dr. Raymond Kim, our Symposium Host (raymond.kim@uhn.ca) for more information.